US Stock MarketDetailed Quotes

Abbott Laboratories (ABT)

Watchlist
  • 102.030
  • -1.060-1.03%
Close Sep 15 15:59 ET
  • 102.000
  • -0.030-0.03%
Pre 05:38 ET
176.55BMarket Cap33.02P/E (TTM)

About Abbott Laboratories Company

Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. It operates through the following segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment focuses on branded generic pharmaceuticals that are manufactured worldwide and marketed and sold outside the United States, primarily in emerging markets. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, clinics, physicians' offices, retailers, government agencies, and alternative care testing sites. The Nutritional Products segment oversees the worldwide sale of pediatric and adult nutritional products. The Medical Devices segment offers a broad range of rhythm management, electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, as well as diabetes care and continuous glucose monitoring products. It also provides neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

Company Profile

SymbolABT
Company NameAbbott Laboratories
Listing DateJan 1, 1929
Issue Price32.00
ISINUS0028241000
Founded1888
CEOMr. Robert B. Ford
MarketNYSE
Employees115000
Fiscal Year Ends12-31
Address100 Abbott Park Road
CityAbbott Park
ProvinceIllinois
CountryUnited States of America
Zip Code60064-6400
Phone1-224-667-6100

Company Executives

  • Name
  • Position
  • Salary
  • Robert B. Ford
  • Chairman of the Board and Chief Executive Officer
  • 24.20M
  • Philip P. Boudreau
  • Executive Vice President, Finance and Chief Financial Officer
  • 9.09M
  • John A. Mccoy, Jr
  • Vice President, Finance, Controller and Principal Accounting Officer
  • --
  • Mary K. Moreland
  • Executive Vice President, Human Resources
  • --
  • Lisa D. Earnhardt
  • Executive Vice President and Group President, Medical Devices
  • 8.07M
  • Elizabeth C. Cushman
  • Executive Vice President, General Counsel and Secretary
  • --
  • Louis H. Morrone
  • Executive Vice President, Core Diagnostics
  • --
  • Eric Shroff
  • Senior Vice President, Rapid and Molecular Diagnostics
  • --
  • Daniel Gesua Sive Salvadori
  • Executive Vice President and Group President, Established Pharmaceuticals and Nutritional Products
  • 6.53M
  • Christopher J. Scoggins
  • Executive Vice President, Diabetes Care
  • 6.60M
  • Patricia P. Gonzalez
  • Independent Director
  • 341.91K
  • Nita Ahuja, M.D.
  • Independent Director
  • --
  • Nancy Mckinstry
  • Lead Independent Director
  • 406.67K
  • Michelle A. Kumbier
  • Independent Director
  • 341.91K
  • Claire Babineaux-Fontenot
  • Independent Director
  • 366.91K
  • Michael G. O’Grady
  • Independent Director
  • 335.91K
  • Michael F. Roman
  • Independent Director
  • 357.57K
  • John G. Stratton
  • Independent Director
  • 388.57K
  • Daniel J. Starks
  • Independent Director
  • 360.91K
  • General Darren W. McDew, U.S.A.F. (Ret.)
  • Independent Director
  • 335.91K
  • Dr. Sally E. Blount, PhD
  • Independent Director
  • 374.34K
  • Kevin Conroy
  • Independent Director
  • --
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
On September 1, U.S. Eastern Time, the U.S. military launched a new round of strikes against Iran in response to recent attempts by the Isla Show More